Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Waldenstrom Macroglobulinemia 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Chromosome 17 deletion 1

Interventions

Cyclophosphamide 38Tacrolimus 35Methotrexate 29fludarabine phosphate 24Busulfan 24Cyclosporine 23Antilymphocyte Serum 23Mycophenolic Acid 20fludarabine 18Peripheral Blood Stem Cell Transplantation 18Melphalan 18Methylprednisolone 16Filgrastim 16Radiotherapy 15Sirolimus 14Whole-Body Irradiation 13thymoglobulin 8Stem Cell Transplantation 8Thiotepa 7Cord Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 6Transplantation 5Hematopoietic Stem Cell Transplantation 5Flow Cytometry 5Etoposide 5Alemtuzumab 5Cyclosporins 4Bone Marrow Transplantation 4Therapeutics 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Atorvastatin × Myeloid × Clear all
NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Loyola University

Phase 3 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡